FRE — Fresenius SE & Co KGaA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Fresenius SE & Co KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	36,277	37,520	21,532	22,299	21,833
Cost of Revenue
Gross Profit	10,316	10,311	5,403	5,058	5,378
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	31,892	33,362	19,720	21,156	20,051
Operating Profit	4,385	4,158	1,812	1,143	1,782
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	3,726	3,652	1,597	715	1,388
Provision for Income Taxes
Net Income After Taxes	2,823	2,819	1,222	238	867
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1,707	1,818	1,372	-594	471
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,707	1,818	1,372	-594	471
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.35	2.63	2.33	2.1	2.39
Dividends per Share